Blood coagulation factor XIII: structure and function.

[1]  J. Fachet,et al.  A Simple, Quick One-step ELISA Assay for the Determination of Complex Plasma Factor XIII (A2B2) , 2000, Thrombosis and Haemostasis.

[2]  B. A. Fox,et al.  Identification of the Calcium Binding Site and a Novel Ytterbium Site in Blood Coagulation Factor XIII by X-ray Crystallography* , 1999, The Journal of Biological Chemistry.

[3]  F. Brosstad,et al.  Platelet adhesion and plasmin generation on immobilized and FXIII crosslinked fibrin(ogen) , 1998 .

[4]  P. Board,et al.  The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. , 1998, Blood.

[5]  P. McKee,et al.  Effect of Phenylglyoxal-modified α2-Antiplasmin on Urokinase-induced Fibrinolysis , 1998, Thrombosis and Haemostasis.

[6]  L. Mccormack,et al.  Prevalence of FXIII V34L in Populations with Different Cardiovascular Risk , 1998, Thrombosis and Haemostasis.

[7]  D. Nurminsky,et al.  Plasma Transglutaminase in Hypertrophic Chondrocytes: Expression and Cell-specific Intracellular Activation Produce Cell Death and Externalization , 1998, The Journal of cell biology.

[8]  G. Melino,et al.  Inhibition of clotting factor XIII activity by nitric oxide. , 1998, Biochemical and Biophysical Research Communications - BBRC.

[9]  R. Willette,et al.  Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. , 1998, Circulation research.

[10]  G. Chelvanayagam,et al.  A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function. , 1998, Blood.

[11]  W. Thompson,et al.  Effect of Crosslinking by Factor XIIIa on the Migration of Vascular Smooth Muscle Cells into Fibrin Gels , 1998 .

[12]  J. Takamatsu,et al.  Arg260‐Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics , 1998, British journal of haematology.

[13]  F. Rodeghiero,et al.  Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. , 1998, Blood.

[14]  M. Weiss,et al.  Two non‐proline cis peptide bonds may be important for factor XIII function , 1998, FEBS letters.

[15]  A. Carter,et al.  Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.

[16]  C. Greenberg,et al.  Analysis of Factor XIII Substrate Specificity Using Recombinant Human Factor XIII and Tissue Transglutaminase Chimeras* , 1997, The Journal of Biological Chemistry.

[17]  J. Schwarzbauer,et al.  Covalent Cross-linking of Fibronectin to Fibrin Is Required for Maximal Cell Adhesion to a Fibronectin-Fibrin Matrix* , 1997, The Journal of Biological Chemistry.

[18]  V. Yee,et al.  Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIIIA subunit , 1997, British journal of haematology.

[19]  C. Arocha-Piñango,et al.  Degradation of human factor XIII by lonomin V, a purified fraction of Lonomia achelous caterpillar venom. , 1997, Thrombosis research.

[20]  Mosesson Mw.  Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. , 1997 .

[21]  C. Arocha-Piñango,et al.  Lonomia achelous caterpillar venom (LACV) selectively inactivates blood clotting factor XIII. , 1997, Thrombosis research.

[22]  V. Yee,et al.  Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families , 1997, Thrombosis and Haemostasis.

[23]  A. Palotie,et al.  Molecular Mechanisms of Mutations in Factor XIII A-subunit Deficiency: In vitro Expression in COS-cells Demonstrates Intracellular Degradation of the Mutant Proteins , 1997, Thrombosis and Haemostasis.

[24]  L. Peltonen,et al.  Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. , 1997, Blood.

[25]  J. Takagi,et al.  Dual functions of transglutaminase in novel cell adhesion. , 1996, Journal of cell science.

[26]  L. Henke,et al.  Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene , 1996, Human Genetics.

[27]  K. Siebenlist,et al.  Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. , 1996, Biochemistry.

[28]  R. Ádány,et al.  Three Different Cell Types Can Synthesize Factor XIII Subunit A in the Human Liver , 1996, Thrombosis and Haemostasis.

[29]  B. Blombäck.  Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis. , 1996, Thrombosis research.

[30]  D. Foster,et al.  Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. , 1996, Journal of biochemistry.

[31]  M. Udvardy,et al.  Promotion of the Crosslinking of Fibrin and α2-antiplasmin by Platelets , 1996, Thrombosis and Haemostasis.

[32]  J. Mcdonagh,et al.  Determinants of Substrate Specificity for Factor XIII , 1996, Seminars in thrombosis and hemostasis.

[33]  S. I. Chung,et al.  Factors That Control Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.

[34]  D. Devine,et al.  Platelet-Associated Factor XIII in Platelet Activation, Adhesion, and Clot Stabilization , 1996, Seminars in thrombosis and hemostasis.

[35]  F. Dapper,et al.  Factor XIII in Ulcerative Leg Disease: Background and Preliminary Clinical Results , 1996, Seminars in thrombosis and hemostasis.

[36]  R. Ádány.  Intracellular Factor XIII: Cellular Distribution of Factor XIII Subunit a in Humans , 1996, Seminars in thrombosis and hemostasis.

[37]  S. I. Chung,et al.  Fibrin Degradation in the Synovial Fluid of Rheumatoid Arthritis Patients: A Model for Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.

[38]  L. Peltonen,et al.  Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. , 1996, Blood.

[39]  A. Stewart,et al.  Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.

[40]  J. Hainfeld,et al.  Orientation of the Carboxy-terminal Regions of Fibrin γ Chain Dimers Determined from the Crosslinked Products Formed in Mixtures of Fibrin, Fragment D, and Factor XIIIa , 1995, Thrombosis and Haemostasis.

[41]  V. Yee,et al.  Factor XIIIA calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit , 1995, British journal of haematology.

[42]  E. Bendixen,et al.  Location of the Major -(-Glutamyl)lysyl Cross-linking Site in Transglutaminase-modified Human Plasminogen (*) , 1995, The Journal of Biological Chemistry.

[43]  L. Pedersen,et al.  Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. , 1995, Thrombosis research.

[44]  M. Packham,et al.  Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII , 1995, Thrombosis and Haemostasis.

[45]  A. Ichinose,et al.  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain. , 1995, The Journal of clinical investigation.

[46]  I. Kurochkin,et al.  Domain structure, stability and domain-domain interactions in recombinant factor XIII. , 1995, Journal of molecular biology.

[47]  L. Muszbek,et al.  Transformation of Cellular Factor XIII into an Active Zymogen Transglutaminase in Thrombin-Stimulated Platelets , 1995, Thrombosis and Haemostasis.

[48]  M. Mendelsohn,et al.  Specific binding of the transglutaminase, platelet factor XIII, to HSP27. , 1994, The Journal of biological chemistry.

[49]  R. Ádány,et al.  Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation. , 1994, Placenta.

[50]  L. Pedersen,et al.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Peltonen,et al.  Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. , 1994, Blood.

[52]  L. Pedersen,et al.  Transglutaminase factor XIII uses proteinase‐like catalytic triad to crosslink macromolecules , 1994, Protein science : a publication of the Protein Society.

[53]  G. Matsueda,et al.  Role of histidine 373 in the catalytic activity of coagulation factor XIII. , 1994, The Journal of biological chemistry.

[54]  D. Devine,et al.  Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa. , 1994, Blood.

[55]  C. Francis,et al.  Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments. , 1993, The Journal of biological chemistry.

[56]  M. Losowsky,et al.  Factor XIII: inherited and acquired deficiency. , 1993, Blood reviews.

[57]  B. Bouma,et al.  Cross‐linking of &agr;2‐antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[58]  P. Holme,et al.  The Difference Between Platelet and Plasma FXIII Used to Study the Mechanism of Platelet Microvesicle Formation , 1993, Thrombosis and Haemostasis.

[59]  E. Bendixen,et al.  Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. , 1993, The Journal of biological chemistry.

[60]  M. Dianzani,et al.  Lipid peroxidation and cancer. , 1993, Critical reviews in oncology/hematology.

[61]  R. Gorodetsky,et al.  Packaging zinc, fibrinogen, and factor XIII in platelet α‐granules , 1993 .

[62]  N. Aoki.  Clot Retraction Increases Clot Resistance to Fibrinolysis by Condensing α2-Plasmin Inhibitor Crosslinked to Fibrin , 1993, Thrombosis and Haemostasis.

[63]  B. Caeiro,et al.  An alternative modality for the immunodetection of the molecular phenotypes of coagulation factor XIIIB. , 1993, Human heredity.

[64]  D. Devine,et al.  Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[65]  L. Zacharski,et al.  Fibrin and Cancer , 1993, Thrombosis and Haemostasis.

[66]  L. Lorand,et al.  Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. , 1993, European journal of biochemistry.

[67]  A. Johnsen,et al.  Different N-terminal forms of α2-plasmin inhibitor in human plasma , 1993 .

[68]  L. Lorand,et al.  Association of the A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma. , 1993, Biochemistry.

[69]  Z. Boda,et al.  Platelet Factor XIII Becomes Active without the Release of Activation Peptide during Platelet Activation , 1993, Thrombosis and Haemostasis.

[70]  Y. Matsuda,et al.  Molecular cloning of the b subunit of mouse coagulation factor XIII and assignment of the gene to chromosome 1: close evolutionary relationship to complement factor H. , 1993, Genomics.

[71]  D. Macdonald,et al.  The tissue distribution of factor XIIIa positive cells , 1993, Histopathology.

[72]  L. Lorand,et al.  Human plasma factor XIII: subunit interactions and activation of zymogen. , 1993, Methods in enzymology.

[73]  A. Bennick,et al.  Early cross‐linked fibrin in human plasma contains α‐polymers with intact fibrinopeptide A , 1992 .

[74]  G. Reed,et al.  Platelet Factor XIII Increases the Fibrinolytic Resistance of Platelet-Rich Clots by Accelerating the Crosslinking of α2-Antiplasmin to Fibrin , 1992, Thrombosis and Haemostasis.

[75]  H. Cleve,et al.  Serum protein polymorphisms in Arab Moslems and Druze of Israel: BF, F13B, AHSG, GC, PLG, PI, and TF. , 1992, Human biology.

[76]  C. Dunwiddie,et al.  Pathways of coagulation activation in situ in rheumatoid synovial tissue. , 1992, Clinical immunology and immunopathology.

[77]  H. Cleve,et al.  Genetic serum protein polymorphisms in Jordanian Arabs: a pilot study of the systems AHSG, BF, F XIII B, GC, PI, PLG and TF. , 1992, Gene geography : a computerized bulletin on human gene frequencies.

[78]  J. Murray,et al.  A tetranucleotide repeat for the F13B locus. , 1992, Nucleic acids research.

[79]  R. Ádány,et al.  Marker profile, enzyme activity, and function of a human myelomonocytic leukemia cell line. , 1992, Cellular immunology.

[80]  S. Easteal,et al.  Genetic affinities of oceanic populations based on RFLP and haplotype analysis of genetic loci on three chromosomes. , 1992, Human biology.

[81]  K. Siebenlist,et al.  Factors affecting gamma-chain multimer formation in cross-linked fibrin. , 1992, Biochemistry.

[82]  J. Shafer,et al.  Interactions of factor XIII with fibrin as substrate and cofactor. , 1992, Biochemistry.

[83]  Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. , 1992, Biochimica et biophysica acta.

[84]  Mosesson Mw.  The assembly and structure of the fibrin clot. , 1992 .

[85]  K. Siebenlist,et al.  Factors affecting γ-chain multimer formation in cross-linked fibrin , 1992 .

[86]  Z. Nemes.  Differentiation markers in hemangiopericytoma , 1992 .

[87]  G. Asijee,et al.  Cytoskeletal assembly and vinculin-cytoskeleton interaction in different phases of the activation of bovine platelets. , 1992, Cell motility and the cytoskeleton.

[88]  N. Saha,et al.  Population genetics of coagulation factor XIIIB in three ethnic groups of Singapore. , 1992, Annals of human biology.

[89]  J. Meunier,et al.  Purification and properties of factor XIII from human placenta. , 1992, The International journal of biochemistry.

[90]  M. Mendelsohn,et al.  The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[91]  V. Chang,et al.  Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. , 1991, The Journal of biological chemistry.

[92]  L. Pedersen,et al.  Expression and characterization of human factor IX. Factor IXthr-397 and factor IXval-397. , 1991, The Journal of biological chemistry.

[93]  D. S. Rath,et al.  Tetranucleotide repeat polymorphism at the human coagulation factor XIII A subunit gene (F13A1). , 1991, Nucleic acids research.

[94]  D. S. Rath,et al.  Trinucleotide repeat polymorphism at the human met-tRNA-i gene 1 (TRMI). , 1991, Nucleic acids research.

[95]  C. W. Prince,et al.  Osteopontin, a substrate for transglutaminase and factor XIII activity. , 1991, Biochemical and biophysical research communications.

[96]  J. Shafer,et al.  Role of calcium ion in the generation of factor XIII activity. , 1991, Biochemistry.

[97]  C. M. Cohen,et al.  Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Shainoff,et al.  Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. , 1991, The Journal of biological chemistry.

[99]  E. Tarcsa,et al.  The presence of a covalently cross-linked matrix in human platelets. , 1991, Biochimica et biophysica acta.

[100]  J. Voorhees,et al.  Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. , 1991, The Journal of investigative dermatology.

[101]  L. Lorand,et al.  Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. , 1991, Biochemistry.

[102]  H. Nishimukai,et al.  Polymorphisms of serum proteins in Japanese patients with vascular diseases. I. Factor XIIIB, plasminogen and complement types in primary varicose veins. , 1991, Human heredity.

[103]  R. Pascone,et al.  Genetic polymorphisms of the A and B subunits of human coagulation factor XIII in mainland Italy and Sardinia: Description of a new FXIIIA variant allele , 1991, Electrophoresis.

[104]  E. Davie,et al.  Nucleotide sequence of the gene for the b subunit of human factor XIII. , 1990, Biochemistry.

[105]  L. Lorand,et al.  Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[106]  D. Teller,et al.  Human recombinant factor XIII from Saccharomyces cerevisiae. Crystallization and preliminary x-ray data. , 1990, The Journal of biological chemistry.

[107]  E. Davie,et al.  Structure of transglutaminases. , 1990, The Journal of biological chemistry.

[108]  S. Rodríguez de Córdoba,et al.  Physical linkage of the human genes coding for complement factor H and coagulation factor XIII B subunit. , 1990, Genomics.

[109]  H. Kikuchi,et al.  Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats. , 1990, Journal of neurosurgery.

[110]  A. Stern,et al.  Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. , 1990, Thrombosis research.

[111]  D. Mosher,et al.  Binding and degradation of blood coagulation factor XIII by cultured fibroblasts. , 1990, The Journal of biological chemistry.

[112]  R. Hilgenfeld,et al.  Crystallization of blood coagulation factor XIII by an automated procedure , 1990, FEBS letters.

[113]  P. Wiedemann,et al.  Blood coagulation factor XIII contributes to the development of traction retinal detachment , 1990, Acta ophthalmologica.

[114]  L. Muszbek,et al.  Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). , 1990, The Biochemical journal.

[115]  P. Board,et al.  Expression of Functional Coagulation Factor XIII in Escherichia coli , 1990, Thrombosis and Haemostasis.

[116]  R. Ádány,et al.  Increased density of histiocytes in uterine leiomyomas. , 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[117]  A. Stern,et al.  Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. , 1990, Blood.

[118]  P. Højrup,et al.  Sequence location of a putative transglutaminase cross‐linking site in human vitronectin , 1990, FEBS letters.

[119]  K. Okafuji,et al.  A familial factor XIII subunit B deficiency , 1990, British journal of haematology.

[120]  D. Teller,et al.  Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae. , 1990, Biochemistry.

[121]  S. Reddy,et al.  Synthesis of human coagulation factor XIII in yeast. , 1990, Gene.

[122]  P. Wiedemann,et al.  Nachweis von Gerinnungsfaktor XIII im Glaskörper und periretinalen Membranen bei proliferativen Netzhauterkrankungen , 1990 .

[123]  Piérard Ge,et al.  Factor-XIIIa-positive dendrocytes and the dermal microvascular unit. , 1990 .

[124]  A. Hamsten,et al.  Native fibrin gel networks and factors influencing their formation in health and disease. , 1990, Advances in experimental medicine and biology.

[125]  A. Amorim,et al.  Formal and population genetics of F13A and FUCA1 polymorphisms in northern Portugal. , 1990, Human heredity.

[126]  N. Isogai,et al.  Wound healing at the site of microvascular anastomosis: Fibrin‐stabilizing factor XIII administration and its effects , 1990, Microsurgery.

[127]  H. Saito,et al.  Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. , 1990, Gynecologic and obstetric investigation.

[128]  R. Colman,et al.  Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. , 1990, Thrombosis research.

[129]  S. Chien,et al.  Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis , 1990, Advances in Experimental Medicine and Biology.

[130]  R. Ádány,et al.  Factors of the Extrinsic Pathway of Blood Coagulation in Tumour Associated Macrophages , 1989, Thrombosis and Haemostasis.

[131]  Francis Jl.  Haemostasis and cancer. , 1989 .

[132]  O. Miura,et al.  Expression and characterization of pro alpha 2-plasmin inhibitor. , 1989, Journal of biochemistry.

[133]  N. Penneys,et al.  Factor XIIIa is expressed by fibroblasts in fibrovascular tumors * , 1989, Journal of cutaneous pathology.

[134]  B. Nickoloff,et al.  Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin , 1989, The British journal of dermatology.

[135]  J. Shafer,et al.  Alpha-thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity. , 1989, Biochemistry.

[136]  H. Takami,et al.  Factor XIII is not involved in human platelet-collagen interaction. , 1989, The Tohoku journal of experimental medicine.

[137]  M. Poon,et al.  Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. , 1989, The Journal of clinical investigation.

[138]  K. Achyuthan,et al.  Human mononuclear phagocyte transglutaminase activity cross-links fibrin. , 1989, Thrombosis research.

[139]  M. Bröker,et al.  New expression vectors for the fission yeast Schizosaccharomyces pombe , 1989, FEBS letters.

[140]  D. Mosher,et al.  Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. , 1989, The Journal of biological chemistry.

[141]  J. Kroll.  The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[142]  K. Siebenlist,et al.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[143]  J. Dyr,et al.  Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. , 1989, Biochimica et biophysica acta.

[144]  K. Achyuthan,et al.  Tb(III)-ion-binding-induced conformational changes in platelet factor XIII. , 1989, The Biochemical journal.

[145]  H. Erickson,et al.  Electron microscopy and hydrodynamic properties of factor XIII subunits. , 1989, The Journal of biological chemistry.

[146]  B. Morris,et al.  The B subunit of coagulation factor XIII is linked to renin and the Duffy blood group to alpha-spectrin on human chromosome 1. , 1989, Human Heredity.

[147]  R. Ádány,et al.  Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report. , 1989, Haemostasis.

[148]  R. Ferrell,et al.  Genetic studies of low‐abundance human plasma proteins: X. Coagulation factor XIIIB variants in blacks , 1989, Electrophoresis.

[149]  B. Nusgens,et al.  Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. , 1989, Haemostasis.

[150]  J. Enghild,et al.  Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). , 1988, The Biochemical journal.

[151]  T. L. Moser,et al.  Vitronectin is a substrate for transglutaminases. , 1988, Biochemical and biophysical research communications.

[152]  R. Procyk,et al.  Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. , 1988, Biochimica et biophysica acta.

[153]  M. Rabaud,et al.  Biochemical study of adduct synthesis between fibrin monomers and elastin. , 1988, Biomaterials.

[154]  R. Ádány,et al.  Fibrinolysis Resistant Fibrin Deposits in Lymph Nodes with Hodgkin's Disease , 1988, Thrombosis and Haemostasis.

[155]  K. Achyuthan,et al.  b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. , 1988, Biochimica et biophysica acta.

[156]  R. Ádány.  Identification of Factor XIIIa in cutaneous tissue , 1988 .

[157]  D. Devine,et al.  Cytofluorometric Identification of Plasmin-Sensitive Factor XIIIa Binding to Platelets , 1988, Thrombosis and Haemostasis.

[158]  T. Halkier,et al.  Contact activation of blood coagulation is inhibited by plasma factor XIII b-chain. , 1988, Thrombosis research.

[159]  K. Matsui,et al.  Polymorphism of the A subunit of coagulation factor XIII: evidence for subtypes of the FXIIIA*1 and FXIIIA*2 alleles. , 1988, American journal of human genetics.

[160]  E. Davie,et al.  Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[161]  D. Mosher,et al.  Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. , 1988, The Journal of biological chemistry.

[162]  A. Beaudet,et al.  Extensive DNA polymorphism at the factor XIIIa (F13A) locus and linkage to HLA. , 1988, American journal of human genetics.

[163]  R. Colman,et al.  Covalent crosslinking of human coagulation factor V by activated factor XIII from guinea pig megakaryocytes and human plasma. , 1988, Blood.

[164]  P. Board,et al.  Haplotypes of the coagulation factor XIII A subunit locus in normal and deficient subjects. , 1988, American journal of human genetics.

[165]  C. Francis,et al.  Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. , 1988, Blood.

[166]  J. Takagi,et al.  "A" subunit of factor XIII is present on bovine platelet membrane and mediates collagen-induced platelet activation. , 1988, Thrombosis research.

[167]  R. Ádány,et al.  Monocytes of Patients Congenitally Deficient in Plasma Factor XIII Lack Factor XIII Subunit A Antigen and Transglutaminase Activity , 1988, Thrombosis and Haemostasis.

[168]  S. Pizzo,et al.  Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. , 1988, Archives of biochemistry and biophysics.

[169]  H. Dvorak,et al.  Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. , 1988, Journal of immunology.

[170]  R. Ádány,et al.  Characterisation of connective tissue cells containing factor XIII subunit a. , 1988, Journal of clinical pathology.

[171]  R. Ádány,et al.  Intratumoral Fibrin Stabilization , 1988 .

[172]  G. Lynch,et al.  B protein of factor XIII: differentiation between free B and complexed B. , 1988, Blood.

[173]  A. Sturk,et al.  Platelet vinculin: a substrate of activated factor XIII. , 1988, Biochimica et biophysica acta.

[174]  G. Webb,et al.  Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24----p25. , 1988, Cytogenetics and cell genetics.

[175]  H. Cleve,et al.  Analysis of the genetic polymorphism of coagulation factor XIIIB (FXIIIB) by isoelectric focusing , 1988, Electrophoresis.

[176]  L. Patthy,et al.  Detecting homology of distantly related proteins with consensus sequences. , 1987, Journal of molecular biology.

[177]  R. Ádány,et al.  Cells containing Factor VIII subunit a in benign and soft tissue tumours , 1987, Histopathology.

[178]  D. Dykes,et al.  The use of the serum protein factor XIIIB (F XIIIB) in parentage testing. , 1987, American journal of clinical pathology.

[179]  C. Francis,et al.  RAPID FORMATION OF LARGE MOLECULAR WEIGHT O-P0LYMERS IN CROSSLINKED FIBRIN INDUCED BY HIGH FACTOR XIII CONCENTRATIONS: ROLE OF PLATELET FACTOR XIII. , 1987, Thrombosis and Haemostasis.

[180]  R. Ádány,et al.  Expression of factor xiii subunit a in different types of human macrophages , 1987 .

[181]  R. Ádány,et al.  Factor XIII: a marker of mono‐ and megakaryocytopoiesis , 1987, British journal of haematology.

[182]  K. Achyuthan,et al.  Factor XIII binds to the Aα- and Bβ- chains in the D-domain of fibrinogen: An immunoblotting study , 1987 .

[183]  M. Shuman,et al.  Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain. , 1987, Blood.

[184]  R. Kannagi,et al.  Platelet factor XIII is activated by calpain. , 1987, Biochemical and biophysical research communications.

[185]  C. Kluft,et al.  Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro , 1987, Thrombosis and Haemostasis.

[186]  R. Ádány,et al.  Erratum , 1998, Environmental Health Perspectives.

[187]  K. Achyuthan,et al.  Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. , 1987, Blood.

[188]  R. Colvin,et al.  Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. , 1987, Blood.

[189]  G. Lynch,et al.  Characterization of thrombospondin as a substrate for factor XIII transglutaminase. , 1987, The Journal of biological chemistry.

[190]  A. Wölpl,et al.  COAGULATION FACTOR XIII A AND B SUBUNITS IN BONE MARROW AND LIVER TRANSPLANTATION , 1987, Transplantation.

[191]  R. Ádány,et al.  Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by the immunohistochemical demonstration of the subunit A of factor XIII (F-XIIIa) , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[192]  M. Carr,et al.  Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels. , 1987, The Journal of laboratory and clinical medicine.

[193]  L. Lorand.  Activation of Blood Coagulation Factor XIII a , 1986, Annals of the New York Academy of Sciences.

[194]  R. Ferrell,et al.  Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB. , 1986, American journal of human genetics.

[195]  C. Lapière,et al.  The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and FXIII. , 1986, Journal of cell science.

[196]  S. Kimura,et al.  Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. , 1986, The Journal of biological chemistry.

[197]  K. Fujikawa,et al.  Amino acid sequence of the a subunit of human factor XIII. , 1986, Biochemistry.

[198]  C. Bird,et al.  Immunohistological demonstration of factors XIIIa and XIIIs in reactive and neoplastic fibroblastic and fibro‐histiocytic lesions , 1986, Histopathology.

[199]  Y. Takahashi,et al.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[200]  E. Amann,et al.  Characterization of cDNA coding for human factor XIIIa. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[201]  D. Mosher,et al.  Thrombospondin is a substrate for blood coagulation factor XIIIa. , 1986, Biochemistry.

[202]  R. Machovich,et al.  THROMBOMODULIN INHIBITS THE ACTIVATION OF FACTOR XIII BY THROMBIN. , 1986, Thrombosis and Haemostasis.

[203]  K. Fujikawa,et al.  Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. , 1986, Biochemistry.

[204]  J. Mcdonagh,et al.  Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. , 1986, The Journal of clinical investigation.

[205]  K. Mann,et al.  Factor V is a substrate for the transamidase factor XIIIa. , 1986, The Journal of biological chemistry.

[206]  J. Mcdonagh,et al.  Covalent crosslinking of von Willebrand factor to fibrin. , 1986, Blood.

[207]  R. Ádány,et al.  Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (F‐XIIIa) in human lymph nodes , 1986, The Journal of pathology.

[208]  J. Mimuro,et al.  Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. , 1986, The Journal of clinical investigation.

[209]  J. Takagi,et al.  Platelet factor XIII. The collagen receptor? , 1986, The Journal of biological chemistry.

[210]  M. Wojtukiewicz,et al.  Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis. , 1986, Folia haematologica.

[211]  M. Metsis,et al.  Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. , 1986, European journal of biochemistry.

[212]  J. Nagy,et al.  Biosynthesis of factor XIII B subunit by human hepatoma cell lines. , 1986, Blood.

[213]  R. Procyk,et al.  Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers--a thiol enhanced process. , 1985, Thrombosis research.

[214]  L. Lorand,et al.  Regulation of formation of factor XIIIa by its fibrin substrates. , 1985, Biochemistry.

[215]  C. Greenberg,et al.  Regulation of plasma factor XIII binding to fibrin in vitro , 1985 .

[216]  C. Greenberg,et al.  The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. , 1985, Blood.

[217]  P. Henriksson,et al.  Identification of intracellular factor XIII in human monocytes and macrophages. , 1985, The Journal of clinical investigation.

[218]  L. Patthy.  Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules , 1985, Cell.

[219]  R. Ádány,et al.  Identification of blood coagulation factor XIII in human peritoneal macrophages. , 1985, European journal of cell biology.

[220]  T. Tamaki,et al.  Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor. , 1985, Blood.

[221]  J. White,et al.  Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets. , 1985, Blood.

[222]  L. Westrick,et al.  Incorporation of thrombospondin into fibrin clots. , 1985, The Journal of biological chemistry.

[223]  M. Shuman,et al.  Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. , 1985, The Journal of clinical investigation.

[224]  R. Procyk,et al.  FXIII induced gelation of human fibrinogen--an alternative thiol enhanced, thrombin independent pathway. , 1985, Thrombosis research.

[225]  B. Horowitz,et al.  Fibronectin and fibrin gel structure. , 1985, The Journal of biological chemistry.

[226]  R. Ádány,et al.  Factor XIII of blood coagulation in human monocytes. , 1985, Thrombosis research.

[227]  Shirley A. Miller,et al.  Gene frequency distribution of the B subunit of factor XIII (F XIIIB) in Minnesota Whites, Blacks and Amerindians , 1985 .

[228]  P. Board,et al.  An extended survey of the genetic polymorphism at the human coagulation factor XIII: a subunit structural locus. , 1985, Human heredity.

[229]  M. Shuman,et al.  Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. , 1984, The Journal of biological chemistry.

[230]  F. Nagao,et al.  [Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study]. , 1984, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[231]  H. Dvorak,et al.  Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. , 1984, Cancer research.

[232]  H. Geuze,et al.  Immunocytochemical Localization of Albumin and Factor XIII in Thin Cryo Sections of Human Blood Platelets , 1984, Thrombosis and Haemostasis.

[233]  J. Gorman,et al.  Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. , 1984, The Journal of biological chemistry.

[234]  P. Board.  Genetic heterogeneity of the B subunit of coagulation factor XIII: resolution of type 2 , 1984, Annals of human genetics.

[235]  J. Mimuro,et al.  Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency. , 1984, Blood.

[236]  M. Losowsky,et al.  Localisation of factor XIII in human tissues using an immunoperoxidase technique. , 1984, Journal of clinical pathology.

[237]  C. Kluft,et al.  The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII. , 1984, Thrombosis research.

[238]  P. Harpel,et al.  Inhibitors of the Fibrinolytic Enzyme System , 1984, Seminars in thrombosis and hemostasis.

[239]  L. Lorand,et al.  Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. , 1983, Biochemistry.

[240]  D. Mosher,et al.  SPECIFICITY OF FIBRONECTIN‐FIBRIN CROSS‐LINKING * , 1983, Annals of the New York Academy of Sciences.

[241]  D. Mosher,et al.  In vitro formation of disulfide-bonded fibronectin multimers. , 1983, The Journal of biological chemistry.

[242]  P. Janmey,et al.  Fibronectin. Effect of disulfide bond reduction on its physical and functional properties. , 1983, The Journal of biological chemistry.

[243]  R. Nossal,et al.  Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots. , 1983, Thrombosis research.

[244]  L. Lorand,et al.  Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen. , 1983, The Journal of clinical investigation.

[245]  L. McIntire,et al.  Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. , 1983, Thrombosis research.

[246]  K. Nitta,et al.  CROSS-LINKING OF FIBRIN BY ACTIVATED FACTOR XIII STIMULATES ATTACHMENT, MORPHOLOGICAL CHANGES AND PROLIFERATION OF FIBROBLASTS , 1983 .

[247]  J. E. Folk.  Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. , 1983, Advances in enzymology and related areas of molecular biology.

[248]  T. Tamaki,et al.  Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. , 1982, Journal of Biological Chemistry.

[249]  N. Aoki,et al.  Reversible cross-linking of α2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor , 1982 .

[250]  M. Shuman,et al.  The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. , 1982, The Journal of biological chemistry.

[251]  Y. Sakata,et al.  Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. , 1982, The Journal of clinical investigation.

[252]  H. Bruhn.  Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin. , 1981, Thrombosis and haemostasis.

[253]  S. Ikematsu.  An approach to the metabolism of factor XIII. , 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

[254]  J. Baguet,et al.  Skin healing and fibrin stabilizing factor blood levels in the rabbit fetus. , 1981, The Journal of surgical research.

[255]  T. Tamaki,et al.  Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor , 1981 .

[256]  T. Juji,et al.  Genetic polymorphism of the a subunit of human coagulation factor XIII in Japanese , 1981, Japanese Journal of Human Genetics.

[257]  A. Veis,et al.  Ca2+-dependent cross-linking processes in human platelets. , 1981, Biochimica et biophysica acta.

[258]  L. Lorand,et al.  Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects. , 1981, Biochemistry.

[259]  J. Mcdonagh,et al.  Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin , 1981, FEBS letters.

[260]  J. Gorman,et al.  Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. , 1981, The Journal of biological chemistry.

[261]  L. Lorand,et al.  Modification of shear modulus and creep compliance of fibrin clots by fibronectin. , 1981, Biophysical chemistry.

[262]  J. Hermans,et al.  Cross-linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers. , 1981, Science.

[263]  L. Glynn.  Tissue repair and regeneration , 1981 .

[264]  A. Bloom.  Haemostasis and thrombosis , 1981 .

[265]  H. Miyata,et al.  Plasma factor XIII levels in children with renal disease. , 1981, Nephron.

[266]  L. Lorand,et al.  Factor XIII (fibrin-stabilizing factor). , 1981, Methods in enzymology.

[267]  T. Newcomb,et al.  Clot retraction in a factor XIII free system. , 2009, Scandinavian journal of haematology.

[268]  J. E. Folk,et al.  Half-of-the-sites and all-of-the-sites reactivity in human plasma blood coagulation factor XIIIa. , 1980, The Journal of biological chemistry.

[269]  R. Nossal,et al.  Rigidity of fibrin gels as measured by quasielastic light scattering , 1980, Biopolymers.

[270]  F. Grinnell,et al.  Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin) , 1980, Cell.

[271]  Y. Sakata,et al.  Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. , 1980, The Journal of clinical investigation.

[272]  A. Veis,et al.  Factor XIIIa-catalyzed cross-linking of platelet and muscle actin. Regulation by nucleotides. , 1980, Biochimica et biophysica acta.

[273]  J. Shainoff,et al.  Crosslinking of Monomeric Fibrin by Factor XIIIa , 1979, Thrombosis and Haemostasis.

[274]  D. Mosher,et al.  Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. , 1979, The Journal of clinical investigation.

[275]  Board Pg.  Genetic polymorphism of the A subunit of human coagulation factor XIII. , 1979 .

[276]  P. Gaffney,et al.  Fibrin crosslinks and lysis rates. , 1979, Thrombosis research.

[277]  G. Siefring,et al.  Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle. , 1979, Archives of biochemistry and biophysics.

[278]  L. Lorand,et al.  Ca2+-related regulatory function of fibrinogen. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[279]  D. Nyman,et al.  Quantitative Estimation of Coagulation Factors in Liver Disease. The Diagnostic and Prognostic Value of Factor XIII, Factor V and Plasminogen , 1978, Thrombosis and Haemostasis.

[280]  T. Urayama,et al.  The role of factor XIII in fibroblast proliferation. , 1978, The Japanese journal of experimental medicine.

[281]  J. Finlayson,et al.  The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases , 1977 .

[282]  M. Losowsky,et al.  Plasma Factor XIII and Platelet Factor XIII in Hyperlipaemia , 1976, Thrombosis and Haemostasis.

[283]  A. Vaheri,et al.  Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII , 1976, Cell.

[284]  J. Mcdonagh,et al.  Subcellular distribution of fibrinogen and factor XIII in human blood platelets. , 1976, Thrombosis research.

[285]  Ş. Ozsoylu,et al.  Platelet aggregation in congenital factor XIII deficiency. , 1976, Acta haematologica.

[286]  H. Kanaide,et al.  Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa). , 1976, The Journal of laboratory and clinical medicine.

[287]  F. Haverkate.  Lysis of Crosslinked and Non-Crosslinked Purified Fibrin , 1975, Thrombosis and Haemostasis.

[288]  P. Cohen,et al.  Distribution of Fibrinogen, and Platelet Factors 4 and XIII in Subcellular Fractions of Human Platelets , 1975, British journal of haematology.

[289]  D. Mosher.  Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. , 1975, The Journal of biological chemistry.

[290]  J. Hermans,et al.  Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin cells. , 1975, Thrombosis research.

[291]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[292]  B. Rudas,et al.  The Effect of Factor XIII on Wound Granulation in the Rat , 1974, Thrombosis and Haemostasis.

[293]  H. Hartert.  Rheo-simulation: a new method for the assay of clotting process and factor XIII. A preliminary report. , 1974, Biorheology.

[294]  R. Cooke.  Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity. , 1974, The Biochemical journal.

[295]  L. Lorand,et al.  Fibrin-stabilizing Factor (Factor XIII) in the Fetus and the Newborn Infant , 1974, Pediatric Research.

[296]  L. Lorand,et al.  Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. , 1974, Biochemistry.

[297]  K. Zimmermann,et al.  Prophylaxe postoperativer Wundheilungsstörungen durch Faktor-XIII-Substitution , 1974 .

[298]  P. Kierulf,et al.  Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF). , 1974, Thrombosis research.

[299]  S. I. Chung,et al.  Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. , 1974, The Journal of biological chemistry.

[300]  J. Joist,et al.  Retention of Platelet Fibrin Stabilizing Factor during the Platelet Release Reaction and Clot Retraction , 1973, Thrombosis and Haemostasis.

[301]  S. Chung.  COMPARATIVE STUDIES ON TISSUE TRANSGLUTAMINASE AND FACTOR XIII , 1972, Annals of the New York Academy of Sciences.

[302]  R. Wagner,et al.  DEMONSTRATION OF FACTOR XIII IN HUMAN MEGAKARYOCYTES BY A FLUORESCENT ANTIBODY TECHNIQUE * , 1972, Annals of the New York Academy of Sciences.

[303]  J. Mcdonagh,et al.  The Influence of Fibrin Crosslinking on the Kinetics of Urokinase‐Induced Clot Lysis * , 1971, British journal of haematology.

[304]  S. Pizzo,et al.  The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. , 1971, The Journal of clinical investigation.

[305]  H. Schwarz,et al.  Faktor-XIII-Konzentration und Wundheilung* , 1970 .

[306]  K. W. Henderson,et al.  The Mechanism of Enhanced Streptokinase‐Induced Clot Lysis following In‐vitro Factor‐XIII Inactivation , 1969, British journal of haematology.

[307]  Losowsky Ms,et al.  Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease. , 1969 .

[308]  A. Fletcher,et al.  Enzymic lysis of plasma clots: The influence of fibrin stabilization on lysis rates , 1967 .

[309]  M. Rikover,et al.  Factor 13 deficiency with severe hemorrhagic diathesis. , 1966, Blood.

[310]  L. Lorand,et al.  Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation. , 1966, Biochemistry.

[311]  L. Lorand,et al.  Accelerated Lysis of Blood Clots , 1962, Nature.

[312]  F. Duckert,et al.  The Influence of Fibrin Stabilizing Factor on the Growth of Fibroblats in vitro and Wound Healing , 1961, Thrombosis and Haemostasis.

[313]  A. Loewy,et al.  Fibrinase. IV. Effect on fibrin solubility. , 1961, The Journal of biological chemistry.

[314]  A. Loewy,et al.  Fibrinase. I. Purification of substrate and enzyme. , 1961, The Journal of biological chemistry.

[315]  A. Loewy,et al.  Fibrinase III. Some enzymatic properties. , 1961, The Journal of biological chemistry.

[316]  A. Loewy,et al.  Fibrinase. II. Some physical properties. , 1961, The Journal of biological chemistry.

[317]  F. Duckert,et al.  A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency , 1961, Thrombosis and Haemostasis.

[318]  C. Veneziale,et al.  Purification of the factor involved in the formation of urea-insoluble fibrin. , 1957, Biochimica et biophysica acta.

[319]  Lüscher Ef.  [Fibrin-stabilizing factor from thrombocytes]. , 1957 .

[320]  L. Lorand,et al.  On the Solubility of Fibrin Clots. , 1948, Science.

[321]  L. Lorand.  A study on the solubility of fibrin clots in urea. , 1948, Hungarica acta physiologica.

[322]  K. Robbins.  A STUDY ON THE CONVERSION OF FIBRINOGEN TO FIBRIN , 1944 .

[323]  J. Mellanby,et al.  Calcium and blood coagulation , 1940, Proceedings of the Royal Society of London. Series B - Biological Sciences.